Idexx Laboratories (IDXX) Tax Provisions (2009 - 2026)

Idexx Laboratories' Tax Provisions history runs 18 years deep, the most recent figure standing at $77.0 million for Q1 2026.

• In Q1 2026, Tax Provisions rose 14.23% year-over-year to $77.0 million; the TTM figure through Mar 2026 stood at $274.3 million (up 19.54% YoY), while the FY2025 annual figure was $264.7 million, up 19.26% from the prior year.
• Tax Provisions for Q1 2026 stood at $77.0 million, up from $58.8 million in the prior quarter.
• The five-year high for Tax Provisions was $77.0 million in Q1 2026, with the low at $39.1 million in Q2 2022.
• The 5-year median for Tax Provisions is $55.8 million (2024), against an average of $56.5 million.
• The sharpest annual moves came in 2022 and 2023: Tax Provisions dropped 20.4% in 2022, then surged 57.77% in 2023.
• Idexx Laboratories' Tax Provisions stood at $41.0 million in 2022, then climbed by 10.09% to $45.1 million in 2023, then retreated by 10.87% to $40.2 million in 2024, then surged by 46.12% to $58.8 million in 2025, then soared by 30.96% to $77.0 million in 2026.
• Business Quant data shows IDXX's Tax Provisions at $77.0 million in Q1 2026, $58.8 million in Q4 2025, and $70.2 million in Q3 2025.